Global and United States Sabin Inactivated Polio vaccine (sIPV) Market Report & Forecast 2022-2028

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Market Analysis and Insights: Global and United States Sabin Inactivated Polio vaccine (sIPV) Market
This report focuses on global and United States Sabin Inactivated Polio vaccine (sIPV) market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Sabin Inactivated Polio vaccine (sIPV) market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Vials accounting for % of the Sabin Inactivated Polio vaccine (sIPV) global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospitals was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Sabin Inactivated Polio vaccine (sIPV) market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period  2022-2028.

Global Sabin Inactivated Polio vaccine (sIPV) Scope and Market Size
Sabin Inactivated Polio vaccine (sIPV) market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Sabin Inactivated Polio vaccine (sIPV) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Sabin Inactivated Polio vaccine (sIPV) market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Vials
    Syringes

Segment by Application
    Hospitals
    Clinics
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Biokangtai
    Sinovac
    Imbcams
    Intravacc
    Beijing Biological

 1 Study Coverage
    1.1 Sabin Inactivated Polio vaccine (sIPV) Product Introduction
    1.2 Global Sabin Inactivated Polio vaccine (sIPV) Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Sabin Inactivated Polio vaccine (sIPV) Sales in Volume for the Year 2017-2028
    1.3 United States Sabin Inactivated Polio vaccine (sIPV) Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Sabin Inactivated Polio vaccine (sIPV) Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Sabin Inactivated Polio vaccine (sIPV) Sales in Volume for the Year 2017-2028
    1.4 Sabin Inactivated Polio vaccine (sIPV) Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Sabin Inactivated Polio vaccine (sIPV) in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Sabin Inactivated Polio vaccine (sIPV) Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Sabin Inactivated Polio vaccine (sIPV) Market Dynamics
        1.5.1 Sabin Inactivated Polio vaccine (sIPV) Industry Trends
        1.5.2 Sabin Inactivated Polio vaccine (sIPV) Market Drivers
        1.5.3 Sabin Inactivated Polio vaccine (sIPV) Market Challenges
        1.5.4 Sabin Inactivated Polio vaccine (sIPV) Market Restraints
    1.6 Study Objectives
    1.7 Years Considered

 2 Market by Type
    2.1 Sabin Inactivated Polio vaccine (sIPV) Market Segment by Type
        2.1.1 Vials
        2.1.2 Syringes
    2.2 Global Sabin Inactivated Polio vaccine (sIPV) Market Size by Type
        2.2.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Sabin Inactivated Polio vaccine (sIPV) Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Sabin Inactivated Polio vaccine (sIPV) Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Sabin Inactivated Polio vaccine (sIPV) Market Size by Type
        2.3.1 United States Sabin Inactivated Polio vaccine (sIPV) Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Sabin Inactivated Polio vaccine (sIPV) Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Sabin Inactivated Polio vaccine (sIPV) Average Selling Price (ASP) by Type (2017, 2022 & 2028)

 3 Market by Application
    3.1 Sabin Inactivated Polio vaccine (sIPV) Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Clinics
        3.1.3 Others
    3.2 Global Sabin Inactivated Polio vaccine (sIPV) Market Size by Application
        3.2.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Sabin Inactivated Polio vaccine (sIPV) Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Sabin Inactivated Polio vaccine (sIPV) Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Sabin Inactivated Polio vaccine (sIPV) Market Size by Application
        3.3.1 United States Sabin Inactivated Polio vaccine (sIPV) Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Sabin Inactivated Polio vaccine (sIPV) Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Sabin Inactivated Polio vaccine (sIPV) Average Selling Price (ASP) by Application (2017, 2022 & 2028)

 4 Global Sabin Inactivated Polio vaccine (sIPV) Competitor Landscape by Company
    4.1 Global Sabin Inactivated Polio vaccine (sIPV) Market Size by Company
        4.1.1 Top Global Sabin Inactivated Polio vaccine (sIPV) Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Manufacturer (2017-2022)
        4.1.3 Global Sabin Inactivated Polio vaccine (sIPV) Sales by Manufacturer (2017-2022)
        4.1.4 Global Sabin Inactivated Polio vaccine (sIPV) Price by Manufacturer (2017-2022)
    4.2 Global Sabin Inactivated Polio vaccine (sIPV) Concentration Ratio (CR)
        4.2.1 Sabin Inactivated Polio vaccine (sIPV) Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Sabin Inactivated Polio vaccine (sIPV) in 2021
        4.2.3 Global Sabin Inactivated Polio vaccine (sIPV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Sabin Inactivated Polio vaccine (sIPV) Manufacturing Base Distribution, Product Type
        4.3.1 Global Sabin Inactivated Polio vaccine (sIPV) Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Sabin Inactivated Polio vaccine (sIPV) Product Type
        4.3.3 Date of International Manufacturers Enter into Sabin Inactivated Polio vaccine (sIPV) Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Sabin Inactivated Polio vaccine (sIPV) Market Size by Company
        4.5.1 Top Sabin Inactivated Polio vaccine (sIPV) Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Sabin Inactivated Polio vaccine (sIPV) Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Sabin Inactivated Polio vaccine (sIPV) Sales by Players (2020, 2021 & 2022)

 5 Global Sabin Inactivated Polio vaccine (sIPV) Market Size by Region
    5.1 Global Sabin Inactivated Polio vaccine (sIPV) Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Sabin Inactivated Polio vaccine (sIPV) Market Size in Volume by Region (2017-2028)
        5.2.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales in Volume by Region: 2017-2022
        5.2.2 Global Sabin Inactivated Polio vaccine (sIPV) Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Sabin Inactivated Polio vaccine (sIPV) Market Size in Value by Region (2017-2028)
        5.3.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales in Value by Region: 2017-2022
        5.3.2 Global Sabin Inactivated Polio vaccine (sIPV) Sales in Value by Region: 2023-2028

 6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Sabin Inactivated Polio vaccine (sIPV) Market Size YoY Growth 2017-2028
        6.1.2 North America Sabin Inactivated Polio vaccine (sIPV) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 United States
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Sabin Inactivated Polio vaccine (sIPV) Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Sabin Inactivated Polio vaccine (sIPV) Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 China Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
    6.3 Europe
        6.3.1 Europe Sabin Inactivated Polio vaccine (sIPV) Market Size YoY Growth 2017-2028
        6.3.2 Europe Sabin Inactivated Polio vaccine (sIPV) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Sabin Inactivated Polio vaccine (sIPV) Market Size YoY Growth 2017-2028
        6.4.2 Latin America Sabin Inactivated Polio vaccine (sIPV) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
        6.4.6 Colombia
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Sabin Inactivated Polio vaccine (sIPV) Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Sabin Inactivated Polio vaccine (sIPV) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE

 7 Company Profiles
    7.1 Biokangtai
        7.1.1 Biokangtai Corporation Information
        7.1.2 Biokangtai Description and Business Overview
        7.1.3 Biokangtai Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Biokangtai Sabin Inactivated Polio vaccine (sIPV) Products Offered
        7.1.5 Biokangtai Recent Development
    7.2 Sinovac
        7.2.1 Sinovac Corporation Information
        7.2.2 Sinovac Description and Business Overview
        7.2.3 Sinovac Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Sinovac Sabin Inactivated Polio vaccine (sIPV) Products Offered
        7.2.5 Sinovac Recent Development
    7.3 Imbcams
        7.3.1 Imbcams Corporation Information
        7.3.2 Imbcams Description and Business Overview
        7.3.3 Imbcams Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Imbcams Sabin Inactivated Polio vaccine (sIPV) Products Offered
        7.3.5 Imbcams Recent Development
    7.4 Intravacc
        7.4.1 Intravacc Corporation Information
        7.4.2 Intravacc Description and Business Overview
        7.4.3 Intravacc Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Intravacc Sabin Inactivated Polio vaccine (sIPV) Products Offered
        7.4.5 Intravacc Recent Development
    7.5 Beijing Biological
        7.5.1 Beijing Biological Corporation Information
        7.5.2 Beijing Biological Description and Business Overview
        7.5.3 Beijing Biological Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Beijing Biological Sabin Inactivated Polio vaccine (sIPV) Products Offered
        7.5.5 Beijing Biological Recent Development

 8 Industry Chain and Sales Channels Analysis
    8.1 Sabin Inactivated Polio vaccine (sIPV) Industry Chain Analysis
    8.2 Sabin Inactivated Polio vaccine (sIPV) Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Sabin Inactivated Polio vaccine (sIPV) Distributors
    8.3 Sabin Inactivated Polio vaccine (sIPV) Production Mode & Process
    8.4 Sabin Inactivated Polio vaccine (sIPV) Sales and Marketing
        8.4.1 Sabin Inactivated Polio vaccine (sIPV) Sales Channels
        8.4.2 Sabin Inactivated Polio vaccine (sIPV) Distributors
    8.5 Sabin Inactivated Polio vaccine (sIPV) Customers

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Sabin Inactivated Polio vaccine (sIPV) CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Sabin Inactivated Polio vaccine (sIPV) Market Trends
    Table 3. Sabin Inactivated Polio vaccine (sIPV) Market Drivers
    Table 4. Sabin Inactivated Polio vaccine (sIPV) Market Challenges
    Table 5. Sabin Inactivated Polio vaccine (sIPV) Market Restraints
    Table 6. Global Sabin Inactivated Polio vaccine (sIPV) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Sabin Inactivated Polio vaccine (sIPV) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Sabin Inactivated Polio vaccine (sIPV) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Sabin Inactivated Polio vaccine (sIPV) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Sabin Inactivated Polio vaccine (sIPV) Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Sabin Inactivated Polio vaccine (sIPV) Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Sabin Inactivated Polio vaccine (sIPV) Sales Share by Manufacturer, 2017-2022
    Table 15. Global Sabin Inactivated Polio vaccine (sIPV) Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 16. Global Sabin Inactivated Polio vaccine (sIPV) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Sabin Inactivated Polio vaccine (sIPV) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sabin Inactivated Polio vaccine (sIPV) as of 2021)
    Table 18. Top Players of Sabin Inactivated Polio vaccine (sIPV) in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Sabin Inactivated Polio vaccine (sIPV) Product Type
    Table 20. Date of International Manufacturers Enter into Sabin Inactivated Polio vaccine (sIPV) Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Sabin Inactivated Polio vaccine (sIPV) Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Sabin Inactivated Polio vaccine (sIPV) Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Sabin Inactivated Polio vaccine (sIPV) Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Sabin Inactivated Polio vaccine (sIPV) Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Sabin Inactivated Polio vaccine (sIPV) Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Sabin Inactivated Polio vaccine (sIPV) Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Sabin Inactivated Polio vaccine (sIPV) Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Sabin Inactivated Polio vaccine (sIPV) Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Sabin Inactivated Polio vaccine (sIPV) Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Sabin Inactivated Polio vaccine (sIPV) Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Sabin Inactivated Polio vaccine (sIPV) Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Sabin Inactivated Polio vaccine (sIPV) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Sabin Inactivated Polio vaccine (sIPV) Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Sabin Inactivated Polio vaccine (sIPV) Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Sabin Inactivated Polio vaccine (sIPV) Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Sabin Inactivated Polio vaccine (sIPV) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Sabin Inactivated Polio vaccine (sIPV) Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Sabin Inactivated Polio vaccine (sIPV) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Sabin Inactivated Polio vaccine (sIPV) Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Sabin Inactivated Polio vaccine (sIPV) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Biokangtai Corporation Information
    Table 43. Biokangtai Description and Business Overview
    Table 44. Biokangtai Sabin Inactivated Polio vaccine (sIPV) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 45. Biokangtai Sabin Inactivated Polio vaccine (sIPV) Product
    Table 46. Biokangtai Recent Development
    Table 47. Sinovac Corporation Information
    Table 48. Sinovac Description and Business Overview
    Table 49. Sinovac Sabin Inactivated Polio vaccine (sIPV) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 50. Sinovac Product
    Table 51. Sinovac Recent Development
    Table 52. Imbcams Corporation Information
    Table 53. Imbcams Description and Business Overview
    Table 54. Imbcams Sabin Inactivated Polio vaccine (sIPV) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 55. Imbcams Product
    Table 56. Imbcams Recent Development
    Table 57. Intravacc Corporation Information
    Table 58. Intravacc Description and Business Overview
    Table 59. Intravacc Sabin Inactivated Polio vaccine (sIPV) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 60. Intravacc Product
    Table 61. Intravacc Recent Development
    Table 62. Beijing Biological Corporation Information
    Table 63. Beijing Biological Description and Business Overview
    Table 64. Beijing Biological Sabin Inactivated Polio vaccine (sIPV) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 65. Beijing Biological Product
    Table 66. Beijing Biological Recent Development
    Table 67. Key Raw Materials Lists
    Table 68. Raw Materials Key Suppliers Lists
    Table 69. Sabin Inactivated Polio vaccine (sIPV) Customers List
    Table 70. Sabin Inactivated Polio vaccine (sIPV) Distributors List
    Table 71. Research Programs/Design for This Report
    Table 72. Key Data Information from Secondary Sources
    Table 73. Key Data Information from Primary Sources
List of Figures
    Figure 1. Sabin Inactivated Polio vaccine (sIPV) Product Picture
    Figure 2. Global Sabin Inactivated Polio vaccine (sIPV) Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Sabin Inactivated Polio vaccine (sIPV) Market Size 2017-2028 (US$ Million)
    Figure 4. Global Sabin Inactivated Polio vaccine (sIPV) Sales 2017-2028 (K Units)
    Figure 5. United States Sabin Inactivated Polio vaccine (sIPV) Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Sabin Inactivated Polio vaccine (sIPV) Market Size 2017-2028 (US$ Million)
    Figure 7. United States Sabin Inactivated Polio vaccine (sIPV) Sales 2017-2028 (K Units)
    Figure 8. United States Sabin Inactivated Polio vaccine (sIPV) Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Sabin Inactivated Polio vaccine (sIPV) Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Sabin Inactivated Polio vaccine (sIPV) Report Years Considered
    Figure 11. Product Picture of Vials
    Figure 12. Product Picture of Syringes
    Figure 13. Global Sabin Inactivated Polio vaccine (sIPV) Market Share by Type in 2022 & 2028
    Figure 14. Global Sabin Inactivated Polio vaccine (sIPV) Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Sabin Inactivated Polio vaccine (sIPV) Sales by Type (2017-2028) & (K Units)
    Figure 17. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Sabin Inactivated Polio vaccine (sIPV) Price by Type (2017-2028) & (US$/Unit)
    Figure 19. United States Sabin Inactivated Polio vaccine (sIPV) Market Share by Type in 2022 & 2028
    Figure 20. United States Sabin Inactivated Polio vaccine (sIPV) Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Sabin Inactivated Polio vaccine (sIPV) Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Sabin Inactivated Polio vaccine (sIPV) Sales by Type (2017-2028) & (K Units)
    Figure 23. United States Sabin Inactivated Polio vaccine (sIPV) Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Sabin Inactivated Polio vaccine (sIPV) Price by Type (2017-2028) & (US$/Unit)
    Figure 25. Product Picture of Hospitals
    Figure 26. Product Picture of Clinics
    Figure 27. Product Picture of Others
    Figure 28. Global Sabin Inactivated Polio vaccine (sIPV) Market Share by Application in 2022 & 2028
    Figure 29. Global Sabin Inactivated Polio vaccine (sIPV) Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Sabin Inactivated Polio vaccine (sIPV) Sales by Application (2017-2028) & (K Units)
    Figure 32. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Sabin Inactivated Polio vaccine (sIPV) Price by Application (2017-2028) & (US$/Unit)
    Figure 34. United States Sabin Inactivated Polio vaccine (sIPV) Market Share by Application in 2022 & 2028
    Figure 35. United States Sabin Inactivated Polio vaccine (sIPV) Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Sabin Inactivated Polio vaccine (sIPV) Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Sabin Inactivated Polio vaccine (sIPV) Sales by Application (2017-2028) & (K Units)
    Figure 38. United States Sabin Inactivated Polio vaccine (sIPV) Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Sabin Inactivated Polio vaccine (sIPV) Price by Application (2017-2028) & (US$/Unit)
    Figure 40. North America Sabin Inactivated Polio vaccine (sIPV) Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 41. North America Sabin Inactivated Polio vaccine (sIPV) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. United States Sabin Inactivated Polio vaccine (sIPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Sabin Inactivated Polio vaccine (sIPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe Sabin Inactivated Polio vaccine (sIPV) Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 45. Europe Sabin Inactivated Polio vaccine (sIPV) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany Sabin Inactivated Polio vaccine (sIPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France Sabin Inactivated Polio vaccine (sIPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. U.K. Sabin Inactivated Polio vaccine (sIPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy Sabin Inactivated Polio vaccine (sIPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia Sabin Inactivated Polio vaccine (sIPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific Sabin Inactivated Polio vaccine (sIPV) Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 52. Asia-Pacific Sabin Inactivated Polio vaccine (sIPV) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China Sabin Inactivated Polio vaccine (sIPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan Sabin Inactivated Polio vaccine (sIPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea Sabin Inactivated Polio vaccine (sIPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India Sabin Inactivated Polio vaccine (sIPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia Sabin Inactivated Polio vaccine (sIPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. China Taiwan Sabin Inactivated Polio vaccine (sIPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Sabin Inactivated Polio vaccine (sIPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Sabin Inactivated Polio vaccine (sIPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Sabin Inactivated Polio vaccine (sIPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Latin America Sabin Inactivated Polio vaccine (sIPV) Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 63. Latin America Sabin Inactivated Polio vaccine (sIPV) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 64. Mexico Sabin Inactivated Polio vaccine (sIPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Brazil Sabin Inactivated Polio vaccine (sIPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Argentina Sabin Inactivated Polio vaccine (sIPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Colombia Sabin Inactivated Polio vaccine (sIPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 69. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Sabin Inactivated Polio vaccine (sIPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Sabin Inactivated Polio vaccine (sIPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. UAE Sabin Inactivated Polio vaccine (sIPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Sabin Inactivated Polio vaccine (sIPV) Value Chain
    Figure 74. Sabin Inactivated Polio vaccine (sIPV) Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed

Market Analysis and Insights: Global and United States Sabin Inactivated Polio vaccine (sIPV) Market
This report focuses on global and United States Sabin Inactivated Polio vaccine (sIPV) market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Sabin Inactivated Polio vaccine (sIPV) market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Vials accounting for % of the Sabin Inactivated Polio vaccine (sIPV) global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospitals was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Sabin Inactivated Polio vaccine (sIPV) market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period  2022-2028.

Global Sabin Inactivated Polio vaccine (sIPV) Scope and Market Size
Sabin Inactivated Polio vaccine (sIPV) market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Sabin Inactivated Polio vaccine (sIPV) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Sabin Inactivated Polio vaccine (sIPV) market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Vials
    Syringes

Segment by Application
    Hospitals
    Clinics
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Biokangtai
    Sinovac
    Imbcams
    Intravacc
    Beijing Biological